Remove 2021 Remove Amortization Remove Liabilities
article thumbnail

Better Buy: Archer Aviation vs. Rocket Lab USA

The Motley Fool

Archer Aviation (NYSE: ACHR) and Rocket Lab USA (NASDAQ: RKLB) are both tiny aerospace companies that went public by merging with special purpose acquisition companies ( SPACs ) in 2021. But in 2021, United Airlines (NASDAQ: UAL) placed a $1 billion order for 200 of Archer's eVTOL aircraft.

article thumbnail

Where Will Nikola Stock Be in 3 Years?

The Motley Fool

In its pre-merger presentation in 2020, it claimed it could ship 600 battery-powered electric trucks (BEVs) in 2021, ship 1,200 BEVs in 2022, and ship 3,500 BEVs in 2023. But in reality, Nikola didn't ship a single BEV in 2021. Metric 2021 2022 2023 Revenue $0 $50.8 million in total liabilities. million $35.8 It had $256.3

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3 Red Flags for ChargePoint's Future

The Motley Fool

ChargePoint (NYSE: CHPT) became the world's first publicly traded electric vehicle (EV) charging network company after it merged with a special purpose acquisition company (SPAC) on March 1, 2021. ChargePoint closed at $30.11 on its first day but now trades at about $3. However, its high debt-to-equity ratio of 2.9

article thumbnail

Why DigitalOcean Is a Top Pick for the Next Bull Market

The Motley Fool

When a company shows a negative D/E ratio, its liabilities exceed its assets -- a sign of potential problems. The company has maintained excellent double-digit revenue growth since it went public in March 2021, as seen in the chart below. This ratio measures a company's financial leverage. On the one hand, the company has high debt.

Debt 245
article thumbnail

Private Credit: From Mid-Market to Real Economy Financier

Blackstone

Private capital financed 86% of LBO transactions in 2023, up from 65% in 2021. These investors are facilitating the movement of assets from bank balance sheets, which are levered and funded by short-duration deposits, to the end accountholders, who want to hold these assets for life against their long-duration liabilities.

Financing 121
article thumbnail

Will MicroStrategy Be a Trillion-Dollar Stock by 2030?

The Motley Fool

But the impairment costs from those purchases caused it to turn unprofitable on a generally accepted accounting principles ( GAAP ) basis in 2020, 2021, and 2022. Its total liabilities also more than quadrupled from $913 million at the end of 2020 to $3.95 billion in the first quarter of 2024.

article thumbnail

Better Recovery Story Buy: Novavax vs. Teladoc

The Motley Fool

The shares have dropped more than 90% from their peak in 2021. Novavax last year launched a plan to improve its cost base, and it's made progress, cutting current liabilities by $1 billion since September. I'm talking about Novavax (NASDAQ: NVAX) and Teladoc Health (NYSE: TDOC). Which makes the better recovery-story buy right now?